Advertisement

Topics

Impax to Report Second Quarter 2017 Results on August 9, 2017

04:49 EDT 29 Jun 2017 | PR Newswire

HAYWARD, Calif., June 29, 2017 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that the Company will release its second quarter 2017 financial results on Wednesday, August 9, 2017, prior to the open of the U.S. financial markets. The Company will host a conference call and live webcast with the investment community at 8:30 a.m., Eastern Time on August 9, 2017. 

The financial results and live webcast will be accessible through the Investor Relations section of the Company's Web site at http://investors.impaxlabs.com.

To access the call through a conference line, dial (877) 356-3814 (in the U.S.) and (706) 758-0033 (international callers). The conference ID is 48618927.

A replay of the conference call will be available for seven days shortly after the call. To access the replay, dial (855) 859-2056 (in the U.S.) and (404) 537-3406 (international callers). The access code for the replay is 48618927.

About Impax Laboratories, Inc.Impax Laboratories, Inc. (Impax) is a specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Impax Generics division and markets its branded products through the Impax Specialty Pharma division. Additionally, where strategically appropriate, Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies, such as injectables, nasal sprays, inhalers, patches, creams, and ointments.

For more information, visit Impax's website at: www.impaxlabs.com.

Contact:Mark Donohue
Investor Relations and Corporate Communications 
(215) 558-4526
www.impaxlabs.com                                              

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/impax-to-report-second-quarter-2017-results-on-august-9-2017-300481846.html

SOURCE Impax Laboratories, Inc.

NEXT ARTICLE

More From BioPortfolio on "Impax to Report Second Quarter 2017 Results on August 9, 2017"

Quick Search
Advertisement
 

Relevant Topics

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.